Male androgen alopecia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All are diagnosed outpatient male patients with androgenetic alopecia (AGA patients with Type III vertex, Type IV, and Type V); 2. Aged between 20 and 65 years (inclusive); 3. Patients are in good general health, without systemic diseases (such as heart, psychiatric, or scalp diseases); 4. Voluntarily participate in the clinical trial and sign a written informed consent form; 5. Maintain the same hair color, hairstyle, and hair length during the study period.
Exclusion criteria
Exclusion criteria: 1. Patients with scalp wounds or infections; Individuals with severe heart, lung, liver, and kidney dysfunction are deemed unsuitable for inclusion by the researchers; 2. Have used any drugs that may affect hair growth (such as anti androgen drugs, anti hypertensive drugs, hormones, cytotoxic drugs, etc.) within the 18 months prior to enrollment in this trial; 3. Patients allergic to minoxidil; 4. Those who cannot be followed up on time; 5. Some researchers believe that conditions such as hair pulling addiction are not suitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Terminal hair density difference; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total hair density value;Physician's assessment score for clinical improvement.;Patient's self-assessment score for clinical improvement.;Patient satisfaction score.; | — |
Countries
China
Contacts
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine